Peter J. Parker

Allele-informed copy number evaluation of plasma DNA samples from metastatic prostate cancer patients: the PCF_SELECT consortium assay.

M. Rubin, A. Wyatt, H. Beltran, 2022, NAR cancer.

Genome-protective topoisomerase 2a-dependent G2 arrest requires p53 in hTERT-positive cancer cells

F. Ciccarelli, I. Collins, Mathias Cobbaut, 2022, Cancer research.

Immunogenomics of Colorectal Cancer Response to Checkpoint Blockade: Analysis of the KEYNOTE 177 Trial and Validation Cohorts

Mohamed Reda Keddar, C. Swanton, G. Wilson, 2021, Gastroenterology.

Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma

S. Tavaré, M. Loda, A. Tutt, 2021, Cancer cell.

Functional proteomic biomarkers in cancer

P. Parker, B. Larijani, M. Perani, 2015, Annals of the New York Academy of Sciences.

ImmunoCluster provides a computational framework for the nonspecialist to profile high-dimensional cytometry data

F. Ciccarelli, M. Fontenay, P. Barber, 2021, eLife.

Functional Engagement of the PD-1/PD-L1 Complex But Not PD-L1 Expression Is Highly Predictive of Patient Response to Immunotherapy in Non–Small-Cell Lung Cancer

L. Sánchez-Magraner, A. Italiano, A. Urruticoechea, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Targeted siRNA Screen Identifies Regulators of Cdc42 Activity at the Natural Killer Cell Immunological Synapse

Luis P. Fernandes, F. Fraternali, B. Vojnovic, 2011, Science Signaling.

ImmunoCluster: A computational framework for the non-specialist to immune profile cellular heterogeneity using liquid and imaging mass, and flow cytometry datasets

F. Ciccarelli, C. Harrison, M. Fontenay, 2020, bioRxiv.

Genome-protective topoisomerase 2a-dependent G2 arrest requires p53 in hTERT-positive cancer cells

F. Ciccarelli, I. Collins, Mathias Cobbaut, 2022, Cancer research.